Login / Signup

Protocol for development of a core outcome set for clinical trials in melasma.

Sarah A IbrahimBianca Y KangDaniel I SchlessingerSarah G ChirenJennifer C TangJamie J KirkhamJochen SchmittEmily PoonIan A MaherJoseph F SobankoTodd V CarteeMurad Alam
Published in: BMJ open (2022)
CRD42020214189.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • phase ii
  • open label